| Macrophage polarization: a key event in the secondary phase of acute spinal cord injury X Kong, J Gao Journal of cellular and molecular medicine 21 (5), 941-954, 2017 | 212 | 2017 |
| Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on … X Hao, Z Zheng, H Liu, Y Zhang, J Kang, X Kong, D Rong, G Sun, G Sun, ... Redox Biology 56, 102463, 2022 | 152 | 2022 |
| Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial Y Xia, W Tang, X Qian, X Li, F Cheng, K Wang, F Zhang, C Zhang, D Li, ... Journal for Immunotherapy of Cancer 10 (4), 2022 | 134 | 2022 |
| Overview of the health care system in Hong Kong and its referential significance to mainland China X Kong, Y Yang, J Gao, J Guan, Y Liu, R Wang, B Xing, Y Li, W Ma Journal of the Chinese Medical Association 78 (10), 569-573, 2015 | 132 | 2015 |
| Targeting immune cells in the tumor microenvironment of HCC: new opportunities and challenges X Hao, G Sun, Y Zhang, X Kong, D Rong, J Song, W Tang, X Wang Frontiers in cell and developmental biology 9, 775462, 2021 | 121 | 2021 |
| Advances of medical nanorobots for future cancer treatments X Kong, P Gao, J Wang, Y Fang, KC Hwang Journal of Hematology & Oncology 16 (1), 74, 2023 | 114 | 2023 |
| Automatic detection of acromegaly from facial photographs using machine learning methods X Kong, S Gong, L Su, N Howard, Y Kong EBioMedicine 27, 94-102, 2018 | 103 | 2018 |
| Prognostic nutritional index (PNI) in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator L Chen, P Bai, X Kong, S Huang, Z Wang, X Wang, Y Fang, J Wang Frontiers in cell and developmental biology 9, 656741, 2021 | 91 | 2021 |
| Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer X Kong, Y Qi, X Wang, R Jiang, J Wang, Y Fang, J Gao, KC Hwang Progress in Materials Science 134, 101070, 2023 | 84 | 2023 |
| Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications X Kong, R Cheng, J Wang, Y Fang, KC Hwang Nano Today 36, 101004, 2021 | 77 | 2021 |
| Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy L Chen, X Kong, Z Wang, X Wang, Y Fang, J Wang Journal of cellular and molecular medicine 24 (5), 2993-3021, 2020 | 76 | 2020 |
| Variation in breast cancer subtype incidence and distribution by race/ethnicity in the United States from 2010 to 2015 X Kong, Z Liu, R Cheng, L Sun, S Huang, Y Fang, J Wang JAMA Network Open 3 (10), e2020303-e2020303, 2020 | 73 | 2020 |
| The research progress on the prognostic value of the common hematological parameters in peripheral venous blood in breast cancer L Chen, X Kong, C Yan, Y Fang, J Wang OncoTargets and therapy, 1397-1412, 2020 | 72 | 2020 |
| Endovascular treatment for ruptured and unruptured vertebral artery dissecting aneurysms: a meta-analysis J Guan, G Li, X Kong, C He, J Long, H Qin, H Zhang, R Wang Journal of NeuroInterventional Surgery 9 (6), 558-563, 2017 | 66 | 2017 |
| Melatonin: a potential therapeutic option for breast cancer X Kong, R Gao, Z Wang, X Wang, Y Fang, J Gao, RJ Reiter, J Wang Trends in Endocrinology & Metabolism 31 (11), 859-871, 2020 | 63 | 2020 |
| Pretreatment systemic inflammation response index in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator L Chen, X Kong, Z Wang, X Wang, Y Fang, J Wang Cancer Management and Research, 1543-1567, 2020 | 63 | 2020 |
| Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells Y Fang, Q Zhang, X Wang, X Yang, X Wang, Z Huang, Y Jiao, J Wang International journal of oncology 48 (3), 1016-1028, 2016 | 59 | 2016 |
| LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1 B Ai, X Kong, X Wang, K Zhang, X Yang, J Zhai, R Gao, Y Qi, J Wang, ... Cell death & disease 10 (7), 502, 2019 | 57 | 2019 |
| Comprehensive analysis of the expressionand prognosis for TDO2 in breast cancer Q Liu, J Zhai, X Kong, X Wang, Z Wang, Y Fang, J Wang Molecular Therapy-Oncolytics 17, 153-168, 2020 | 53 | 2020 |
| Immunological therapy: A novel thriving area for triple-negative breast cancer treatment X Wang, Y Qi, X Kong, J Zhai, Y Li, Y Song, J Wang, X Feng, Y Fang Cancer letters 442, 409-428, 2019 | 52 | 2019 |
